Literature DB >> 9171359

Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer.

D J Steger1, J L Workman.   

Abstract

To investigate mechanisms yielding DNase I-hypersensitive sites (DHSs) at gene regulatory regions, we have initiated a biochemical analysis of transcription factor binding and nucleosome remodeling with a region of the human immunodeficiency virus 1 (HIV-1) 5' long terminal repeat (LTR) that harbors constitutive DHSs in vivo. In vitro reconstitution of an HIV-1 5' LTR fragment into nucleosome core particles demonstrates that Sp1, NF-kappaB1, LEF-1, ETS-1 and USF can gain access to their binding sites in HIV-1 nucleosomal DNA. The factor-bound mononucleosomes resist histone displacement from the DNA by the chromatin remodeling activity, SW1-SNF, or the histone chaperone, nucleoplasmin, suggesting that the binding of these factors to nucleosomal HIV-1 sequences forms a stable complex that includes the underlying histones. However, when the HIV-1 5' LTR fragment is incorporated into a nucleosomal array, Sp1 and NF-kappaB1 binding produce regions of enhanced DNase I sensitivity specifically at the HIV-1 nucleosome. These regions resemble the observed in vivo DHSs, yet the HIV-1 nucleosome remains intact even in the presence of nucleoplasmin. Thus, the constitutive DHSs identified at the HIV-1 enhancer in native chromatin may reflect the presence of a ternary complex composed of transcriptional activators, histones and DNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171359      PMCID: PMC1169846          DOI: 10.1093/emboj/16.9.2463

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer.

Authors:  M L Waterman; W H Fischer; K A Jones
Journal:  Genes Dev       Date:  1991-04       Impact factor: 11.361

2.  Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF.

Authors:  P Pognonec; R G Roeder
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 3.  Remodeling chromatin structures for transcription: what happens to the histones?

Authors:  D J Steger; J L Workman
Journal:  Bioessays       Date:  1996-11       Impact factor: 4.345

4.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  GAL4 derivatives function alone and synergistically with mammalian activators in vitro.

Authors:  Y S Lin; M F Carey; M Ptashne; M R Green
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

Review 6.  Nuclease hypersensitive sites in chromatin.

Authors:  D S Gross; W T Garrard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

7.  Chromatin reconstituted from tandemly repeated cloned DNA fragments and core histones: a model system for study of higher order structure.

Authors:  R T Simpson; F Thoma; J M Brubaker
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

8.  The formation and function of DNase I hypersensitive sites in the process of gene activation.

Authors:  S C Elgin
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

9.  A 200 base pair region at the 5' end of the chicken adult beta-globin gene is accessible to nuclease digestion.

Authors:  J D McGhee; W I Wood; M Dolan; J D Engel; G Felsenfeld
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

10.  DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1.

Authors:  E Verdin
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more
  44 in total

Review 1.  ATP-dependent chromatin-remodeling complexes.

Authors:  M Vignali; A H Hassan; K E Neely; J L Workman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor.

Authors:  Shao-Chung Victor Hsia; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors.

Authors:  Lindsey Reynolds; Christopher Ullman; Michael Moore; Mark Isalan; Michelle J West; Paul Clapham; Aaron Klug; Yen Choo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

4.  Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.

Authors:  Alexander V Gasparian; Catherine A Burkhart; Andrei A Purmal; Leonid Brodsky; Mahadeb Pal; Madhi Saranadasa; Dmitry A Bosykh; Mairead Commane; Olga A Guryanova; Srabani Pal; Alfiya Safina; Sergey Sviridov; Igor E Koman; Jean Veith; Anton A Komar; Andrei V Gudkov; Katerina V Gurova
Journal:  Sci Transl Med       Date:  2011-08-10       Impact factor: 17.956

Review 5.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

6.  Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

Authors:  T L Goetz; T L Gu; N A Speck; B J Graves
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  Activation domains drive nucleosome eviction by SWI/SNF.

Authors:  José L Gutiérrez; Mark Chandy; Michael J Carrozza; Jerry L Workman
Journal:  EMBO J       Date:  2007-01-18       Impact factor: 11.598

8.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

9.  HIV latency: present knowledge, future directions.

Authors:  Xavier Contreras; Tina Lenasi; B Matija Peterlin
Journal:  Future Virol       Date:  2006       Impact factor: 1.831

Review 10.  Pioneer factors and their in vitro identification methods.

Authors:  Xinyang Yu; Michael J Buck
Journal:  Mol Genet Genomics       Date:  2020-04-15       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.